Symbols

YI

111·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About YI

111, Inc.

A leading tech-enabled healthcare platform company in China

Industry

Consumer Goods Distribution and Retail

Established Date

Listing Date

09/12/2018

Exchange

NASDAQ Stock Exchange

Full-time Employees

1,238

Fiscal Year Ends

12-31

Website

ir.111.com.cn

Security Type

Depository Receipts (Ordinary Shares)

Office address

3-4/F, No.295 ZuChongZhiRoad, Pudong New Area, Shanghai, 201203, China

Business

Source procurement and online e-commerce for drug sales

Introduction

No. 1 Yaowang, the predecessor of 111, Inc. (formerly known as Yaowang), was incorporated under the laws of the Cayman Islands in May 2013. The company provides hundreds of millions of consumers with better pharmaceutical products and medical services, directly through their online retail pharmacies and indirectly through their offline pharmacy network. According to Frost & Sullivan, 1 Drugstore has been the largest direct selling online pharmacy in China since 2016 in terms of GMV. In 2016, they launched online medical services through their Internet hospitals, 1 clinic, providing consumers with cost-effective online wholesale pharmacies, 1 drug mall, and serving as a one-stop shop for purchasing massive pharmaceutical products such as pharmacies, clinics, and hospitals.

Company Financials

EPS

YI has released its 2025 Q2 earnings. EPS was reported at -0.31, versus the expected 0, missing expectations. The chart below visualizes how YI has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

YI has released its 2025 Q2 earnings report, with revenue of 447.51M, reflecting a YoY change of -5.03%, and net profit of -1.01M, showing a YoY change of -253.99%. The Sankey diagram below clearly presents YI's revenue sources and cost distribution.